"Le CHU de Rouen, au cœur du Campus Santé Rouen Normandie, contribue au développement d’un véritable écosystème dédié à la santé. Ses 10 300 professionnels sont au service d'une triple mission : soigner et prendre soin de chaque patient, former les futurs médecins et soignants et faire avancer la recherche au bénéfice de tous. Avec ses 5 établissements de soins et d'hébergement, le CHU de Rouen est l’établissement support du Groupement hospitalier de territoire (GHT) Rouen Cœur de Seine. Premier employeur de Normandie, il se positionne parmi les 12 plus importants CHU français en termes d’activités."

During the past decade, CHU Rouen conducted 243 clinical trials. In the 10-year time frame, 243 clinical trials started and 50 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 32 clinical trials were completed. i.e. 29.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Rouen" #1 sponsor was "UNICANCER" with 16 trials, followed by "University Hospital, Lille" with 16 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 15 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 14 trials sponsored and "University Hospital, Rouen" with 14 trials sponsored. Other sponsors include 335 different institutions and companies that sponsored additional 154 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Rouen" #1 collaborator was "Ministry of Health, France" with 20 trials as a collaborator, "National Cancer Institute, France" with 9 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 5 trials as a collaborator, "Alzheimer's Association" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 199 different institutions and companies that were collaborators in the rest 169 trials.

According to Clinical.Site data, the most researched conditions in "CHU Rouen" are "Crohn's Disease" (9 trials), "Ulcerative Colitis" (8 trials), "Dementia" (7 trials), "Heart Failure" (7 trials) and "Pancreatic Cancer" (7 trials). Many other conditions were trialed in "CHU Rouen" in a lesser frequency.

Most popular intervention types in "CHU Rouen" are "Drug" (195 trials), "Other" (79 trials), "Device" (67 trials), "Procedure" (44 trials) and "Biological" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Gemcitabine" (8 trials), "cisplatin" (8 trials), "fluorouracil" (8 trials) and "gemcitabine hydrochloride" (6 trials). Other intervention names were less common.

The vast majority of trials in "CHU Rouen" are 389 trials for "All" genders, 18 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "CHU Rouen". 12 are not yet recruiting, 80 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 214 completed trials in CHU Rouen, 2 suspended trials, and 42 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Rouen, 4 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 88 trials that are defined as “Not Applicable".